Latest Income Stories
-Halozyme completes corporate strategy review and affirms priority focus on advancing PEGPH20 and ENHANZE(TM)- SAN DIEGO, Nov. 10, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc.
Revenue Increased 49%, Net Income Increased 51%, Adjusted EBITDA Increased 94% FLINT, Mich., Nov. 10, 2014 /PRNewswire/ -- Diplomat Pharmacy, Inc.
-- Omidria(TM) U.S. Commercial Launch Planned for Early 2015 -- SEATTLE, Nov.
REDWOOD CITY, Calif., Nov. 10, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
LAS VEGAS, Nov.
Revenues, operating profit, EBITDA and net profit for 2014 all continue up; 2014 EBITDA guidance again increased ANN ARBOR, Mich., Nov.
- Net loss of 40,000 subscribers, resulting in an ending subscriber base of 9.1 million RESTON, Va., Nov.
BEIJING, Nov. 10, 2014 /PRNewswire/ -- Cheetah Mobile Inc.
Offsets Decline from Top Client with Revenue Momentum across Offerings and Verticals; Announces Agreement to Acquire Translation Solutions Company with $85 Million of Recurring Revenue in Financial
LAS VEGAS, Nov. 10, 2014 /PRNewswire/ -- Caesars Acquisition Company (NASDAQ: CACQ) today reported the following results for Caesars Growth Partners, LLC ("CGP LLC") for the third quarter 2014.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.